StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NYSE · ARDT·Healthcare

Ardent Health Inc. Stock Analysis & AI Score

Ardent Health Inc. (ARDT) has an ST Score of 50.3 (C+), driven by its Valuation (B) and held back by its Growth (D+). Analysts rate it Buy with a $12.67 price target (+20.9% upside).

Market Closed
$10.48
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
50
ST Score
50.3/100C+

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryMedical - Care Facilities
IPO Date—
Website—
Country—
ExchangeNYSE

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

ARDT
50.3out of 100
Grade C+

Ardent Health Inc. (ARDT) has an ST Score of 50.3 (C+), driven by its Valuation (B) and held back by its Growth (D+). Analysts rate it Buy with a $12.67 price target (+20.9% upside).

Strongest
ValuationB
Weakest
GrowthD+
All factor grades
  • ValuationB
  • Financial StrengthB-
  • MomentumB-
  • ForecastB-
  • SentimentC+
  • ProfitabilityC
  • GrowthD+
  • Piotroski5/9
Score methodology
Press Releases

Contact

ARDT stock: frequently asked questions

What is ARDT's ST Score?

Ardent Health Inc. (ARDT) has an ST Score of 50.3 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is ARDT a buy, hold, or sell?

Analysts rate ARDT a Buy, with a price target of $12.67 (+20.9% vs the current price). Our ST Score grades it C+ (50.3/100). The ST Score is a data-driven signal, not a recommendation.

What are ARDT's factor grades?

Valuation B, Profitability C, Financial Strength B-, Momentum B-, Growth D+, Forecast B-, Sentiment C+.

What is ARDT's valuation grade?

Ardent Health Inc. (ARDT) earns a valuation grade of B, measured against Medical - Care Facilities peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is ARDT's growth grade?

Ardent Health Inc. (ARDT) earns a growth grade of D+, measured against Medical - Care Facilities peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is ARDT's profitability grade?

Ardent Health Inc. (ARDT) earns a profitability grade of C, measured against Medical - Care Facilities peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is ARDT's financial strength grade?

Ardent Health Inc. (ARDT) earns a financial strength grade of B-, measured against Medical - Care Facilities peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for ARDT?

The average analyst price target for Ardent Health Inc. (ARDT) is $12.67 from 12 analysts, which is +20.9% versus the recent price of $10.48.

What is ARDT's Piotroski score?

Ardent Health Inc. (ARDT) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.